The Middle East and Africa MRI Market is expected to reach USD 0.47 billion by 2027 from USD 0.41 billion in 2022, with a CAGR of 2.7% during the forecast period.
Constant evolution in technological advancements, such as the inclusion of MRI with PET or computed tomography, to provide imaging capabilities with less exposure to harmful radiation has increased the adoption of MRI in the MEA region. Moreover, the increasing aging of the population, the growing need for better diagnostic procedures, and the improving healthcare needs are other factors pushing the market on a growth path. According to Globocan, among both sexes, breast and cervical cancers are the most common cancers in Africa, with breast cancer contributing only about 16.6% of all new cases. Therefore, the increasing burden of cancer and the growing awareness among people of the early diagnosis of diseases for their prevention and faster cure is contemplated to show better growth during the prognostic period.
The incidence of multiple sclerosis (MS) increases in several regions, including the Middle East and Africa. For example, among Saudi citizens, the total prevalence of MS was 11.80 per 100,000, and the prevalence will increase by 61.95 / 100,000 over the term. In the United Arab Emirates, the prevalence was highest in the western region. While in South Africa, MS has an incidence of about 1 in 700 or 0.14% of the total population.
In addition, the latest technologically advanced MRI systems, such as hybrid MRI, MRI are combined with X-rays. It is used to treat infertile patients, especially in a developed market, will provide growth opportunities in the years to come.
However, strict regulations and standards for the approval and marketing of MRI devices present a challenge for the market. The high cost and non-availability of MRI tests in small hospitals and clinics will have a negative impact on the market growth. In addition, the increasing use of other options for scanning and adverse effects on biocompatible metal in the patient (like pacemakers, valve replacements, knee caps) will act as a constraint in the MEA MRI market.
This research report on the Middle East and Africa MRI Market has been segmented and sub-segmented into the following categories:
By Field Strength:
Geographically, the United Arab Emirates is expected to dominate the MEA MRI market during the forecast period. This market dominance can be attributed to the latest technological developments, high healthcare spending, and a well-developed market with significant vital players. The Dubai Health Authority offers patient-specific anatomical models, enabling them to perform precise preoperative details and improve communication with patients, leading to a better prognosis, primarily using CT scans or MRIs. Hence, these technological developments support the growth of the MRI market in the United Arab Emirates.
South Africa is projected to grow with a substantial growth rate during the forecast period. Government agencies and healthcare organizations are running various programs to drive the market's growth. They are also focusing on reducing costs for the procedure. In addition, rapid improvements in technology have led to the widespread development of the magnetic resonance imaging systems market in African countries.
KEY MARKET PLAYERS:
Companies playing a significant role in the MEA MRI market are Hitachi Medical Corporation, Toshiba Medical Systems, Siemens Healthcare, GE Healthcare, Imris Inc., Fonar Corporation, Esaote S.P.A, Neusoft Medical System, Aurora Medical Imaging, and Philips Healthcare.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org